VTI.AU · Visioneering Technologies, Inc

-

Please sign in to comment on VTI.AU

1 Comment

Admin

3 years, 7 months ago

Visioneering Technologies, Inc is currently in a long term uptrend where the price is trading 490.9% above its 200 day moving average.

From a valuation standpoint, the stock is 99.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.8.

Visioneering Technologies, Inc's total revenue sank by 9.9% to $3M since the same quarter in the previous year.

Its net income has increased by 31.1% to $-4M since the same quarter in the previous year.

Finally, its free cash flow grew by 67.7% to $-968K since the same quarter in the previous year.

Based on the above factors, Visioneering Technologies, Inc gets an overall score of 4/5.

CurrencyCode	AUD
Exchange	AU
Sector	Healthcare
ISIN	AU000000VTI2
Industry	Medical Devices

Target Price	0.66
Dividend Yield	0.0%
PE Ratio	0.0
Beta	1.57
Market Cap	7M

ABOUT

Visioneering Technologies, Inc

Visioneering Technologies, Inc., a medical device company, designs, manufactures, sells, and distributes contact lenses in North America, Europe, and the Asia-Pacific. Its flagship product is NaturalVue, a multifocal contact lens for adults with presbyopia and children with myopia. The company was founded in 2008 and is based in Alpharetta, Georgia.

VTI.AU · Visioneering Technologies, Inc

-

Visioneering Technologies, Inc

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Visioneering Technologies, Inc using a moving average strategy